AAAAAA

   
Results: 1-13 |
Results: 13
T cell responses to HLA-A0201-restricted peptides derived from human alpha fetoprotein
Authors: Butterfield, LH Meng, WS Koh, A Vollmer, CM Ribas, A Dissette, VB Faull, K Glaspy, JA McBride, WH Economou, JS
Citation: Lh. Butterfield et al., T cell responses to HLA-A0201-restricted peptides derived from human alpha fetoprotein, J IMMUNOL, 166(8), 2001, pp. 5300-5308
Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures
Authors: Frost, PA Butterfield, LH Dissette, VB Economou, JS Bonavida, B
Citation: Pa. Frost et al., Immunosensitization of melanoma tumor cells to non-MHC Fas-mediated killing by MART-1-specific CTL cultures, J IMMUNOL, 166(5), 2001, pp. 3564-3573
Generation of T-cell immunity to a murine melanoma using MART-1-engineereddendritic cells
Authors: Ribas, A Butterfield, LH Hu, B Dissette, VB Chen, AY Koh, A Amarnani, SAN Glaspy, JA McBride, WH Economou, JS
Citation: A. Ribas et al., Generation of T-cell immunity to a murine melanoma using MART-1-engineereddendritic cells, J IMMUNOTH, 23(1), 2000, pp. 59-66
Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication
Authors: Miller, PW Sharma, S Stolina, M Butterfield, LH Luo, J Lin, Y Dohadwala, M Batra, RK Wu, L Economou, JS Dubinett, SM
Citation: Pw. Miller et al., Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication, HUM GENE TH, 11(1), 2000, pp. 53-65
Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein
Authors: Meng, WS Butterfield, LH Ribas, A Heller, JB Dissette, VB Glaspy, JA McBride, WH Economou, JS
Citation: Ws. Meng et al., Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein, MOL IMMUNOL, 37(16), 2000, pp. 943-950
Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice
Authors: Ribas, A Butterfield, LH Hu, B Dissette, VB Meng, WS Koh, A Andrews, KJ Lee, M Amar, SN Glaspy, JA McBride, WH Economou, JS
Citation: A. Ribas et al., Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice, CANCER RES, 60(8), 2000, pp. 2218-2224
Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells
Authors: Andrews, KJ Ribas, A Butterfield, LH Vollmer, CM Eilber, FC Dissette, VB Nelson, SD Shintaku, P Mekhoubad, S Nakayama, T Taniguchi, M Glaspy, JA McBride, WH Economou, JS
Citation: Kj. Andrews et al., Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells, CANCER RES, 60(22), 2000, pp. 6457-6464
Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells
Authors: Ribas, A Butterfield, LH McBride, WH Dissette, VB Koh, A Vollmer, CM Hu, B Chen, AY Glaspy, JA Economou, JS
Citation: A. Ribas et al., Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells, CANC GENE T, 6(6), 1999, pp. 523-536
Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicities
Authors: Ribas, A Bui, LA Butterfield, LH Vollmer, CM Jilani, SM Dissette, VB Glaspy, JA McBride, WH Economou, JS
Citation: A. Ribas et al., Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicities, ANTICANC R, 19(2A), 1999, pp. 1165-1170
p53 selective and nonselective replication of an E1B-deleted adenovirus inhepatocellular carcinoma
Authors: Vollmer, CM Ribas, A Butterfield, LH Dissette, VB Andrews, KJ Eilber, FC Montejo, LD Chen, AY Hu, B Glaspy, JA McBride, WH Economou, JS
Citation: Cm. Vollmer et al., p53 selective and nonselective replication of an E1B-deleted adenovirus inhepatocellular carcinoma, CANCER RES, 59(17), 1999, pp. 4369-4374
alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma
Authors: Vollmer, CM Eilber, FC Butterfield, LH Ribas, A Dissette, VB Koh, A Montejo, LD Lee, MC Andrews, KJ McBride, WH Glaspy, JA Economou, JS
Citation: Cm. Vollmer et al., alpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma, CANCER RES, 59(13), 1999, pp. 3064-3067
Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein
Authors: Butterfield, LH Koh, A Meng, W Vollmer, CM Ribas, A Dissette, V Lee, E Glaspy, JA McBride, WH Economou, JS
Citation: Lh. Butterfield et al., Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein, CANCER RES, 59(13), 1999, pp. 3134-3142
Generation of CD8(+) and CD4(+) T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene
Authors: Perez-Diez, A Butterfield, LH Li, L Chakraborty, NG Economou, JS Mukherji, B
Citation: A. Perez-diez et al., Generation of CD8(+) and CD4(+) T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene, CANCER RES, 58(23), 1998, pp. 5305-5309
Risultati: 1-13 |